1 / 1
Glucagon API: Glucagon is a natural peptide hormone used as an emergency treatment for severe hypoglycemia and studied for its role in metabolic regulation, weight loss, and digestive diagnostics.
Glucagon binds to the glucagon receptor (GCGR) in the liver, stimulating:
It is also being explored in obesity, type 2 diabetes, and dual/triple agonist therapies with GLP-1 and GIP.
Glucagon API is essential for hypoglycemia rescue, diagnostic imaging, and metabolic disorder research.
Glucagon API is mainly utilized in formulating emergency treatments for severe hypoglycemia, acting as a diagnostic aid in gastrointestinal imaging, and serving in research for novel metabolic therapies.
The API is produced via Solid-Phase Peptide Synthesis (SPPS), ensuring a high purity level of ≥99% adhering to GMP-like standards.
Glucagon binds to the hepatic glucagon receptor (GCGR) to trigger glycogen breakdown and elevate blood glucose. It also aids lipolysis and modifies gastrointestinal motility.
Beyond hypoglycemia rescue, it is actively researched for weight loss, obesity management, type 2 diabetes, and multi-agonist therapies combined with GLP-1 and GIP.
Yes, due to its high purity level and GMP-like quality control, Glucagon API is specifically designed for application in injectables and emergency rescue kits.
